Nektar Therapeutics
NKTR
#6172
Rank
NZ$1.54 B
Marketcap
NZ$76.02
Share price
2.25%
Change (1 day)
217.97%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): NZ-$13.62

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$13.63. In 2024 the company made an earnings per share (EPS) of NZ-$15.15 an increase over its 2023 EPS that were of NZ-$37.45.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$13.62-10.1%
2024NZ-$15.15-59.54%
2023NZ-$37.45-25.89%
2022NZ-$50.53-31.12%
2021NZ-$73.3514.86%
2020NZ-$63.86-1.19%
2019NZ-$64.63-163.96%
2018NZ$101.06-725.4%
2017NZ-$16.16-42.73%
2016NZ-$28.2183.33%
2015NZ-$15.3939.53%
2014NZ-$11.03-69.29%
2013NZ-$35.91-6.67%
2012NZ-$38.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
NZ$22.28-263.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.94-121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.98-195.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
NZ$0.01710-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$5.19-138.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
NZ-$1.13-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$3.54-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
NZ$17.85-230.98%๐Ÿ‡บ๐Ÿ‡ธ USA